Back to Search
Start Over
Prognostic factors in metastatic gastric carcinoma.
- Source :
-
Experimental oncology [Exp Oncol] 2019 Jun; Vol. 41 (2), pp. 173-175. - Publication Year :
- 2019
-
Abstract
- Although its incidence has declined over last half-century, gastric cancer remains the second most frequent cause of cancer death in the world. The ⅔ of the patients are metastatic at diagnosis. The current study aimed to identify some determinants of survival in patients with metastatic gastric carcinoma.<br />Materials and Methods: It was a retrospective study that involved 49 patients treated with palliative chemotherapy between January 2000 and December 2010. Factors included: age, gender, performance status, metastatic diagnosis onset (at diagnosis or later); specific metastatic sites, number of metastatic localizations, response to chemotherapy, and hemoglobin rate.<br />Results: In univariate analysis, factors associated to a better survival were: metastasis at diagnosis, good performance status, response to chemotherapy and single metastatic site. Independent factors in multivariate analysis were: metastasis at diagnosis and single metastatic site.<br />Conclusion: Our study confirmed many determinants on survival described in the literature.
- Subjects :
- Adult
Aged
Cisplatin therapeutic use
Combined Modality Therapy
Female
Fluorouracil therapeutic use
Gastrectomy
Humans
Male
Middle Aged
Prognosis
Retrospective Studies
Stomach Neoplasms mortality
Antineoplastic Agents therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Neoplasm Metastasis pathology
Stomach Neoplasms pathology
Stomach Neoplasms therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2312-8852
- Volume :
- 41
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Experimental oncology
- Publication Type :
- Academic Journal
- Accession number :
- 31262152
- Full Text :
- https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.13283